pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection
Blue Earth Diagnostics
Blue Earth Diagnostics Ireland Ltd
Blue Earth Diagnostics clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
- Founded
- 2014
- Employees
- 120
- Programs
- 11
- Drugs
- 12
- Patents
- 0
Blue Earth Diagnostics projects
4 ClinicalTrials.gov programs sponsored by Blue Earth Diagnostics.
Blue Earth Diagnostics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BFB759, Placebo
Blue Earth Diagnostics Ireland Ltd
Atopic dermatitis
1 trial -
Lutetium (177Lu) rhPSMA-10.1 injection
Blue Earth Diagnostics Ireland Ltd
Metastatic castration-resistant prostate cancer (mCRPC)
1 trial -
Placebo, BFB759
Blue Earth Diagnostics Ireland Ltd
Hidradenitis Suppurativa
1 trial -
[68Ga]BED003 injection
Blue Earth Diagnostics Ireland Ltd
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
1 trial
Frequently asked questions
How many clinical projects does Blue Earth Diagnostics have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.